The role of LINC00460 as an oncogene was also reported in hepatocellular carcinoma, pancreatic cancer, kidney malignancy, and prostate cancer (Dong and Quan, 2019; Yang et al., 2020b; Cheng et al., 2021). Here, LINC00460 is linked to hepatocellular carcinoma.